NATALIE O'KELLY: Open Payments
NPI 1518402510 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,533 in 113 payments from 38 companies in 2025. Trend: 2023 $694 · 2024 $2,353 · 2025 $2,533
Food & beverage: $2,533
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $237 |
| Novartis Pharmaceuticals Corporation | 8 | $215 |
| Genentech USA, Inc. | 7 | $170 |
| ABBVIE INC. | 7 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $113 |
| Merck Sharp & Dohme LLC | 4 | $110 |
| Daiichi Sankyo Inc. | 4 | $110 |
| Lilly USA, LLC | 4 | $107 |
| Incyte Corporation | 5 | $101 |
| PFIZER INC. | 4 | $77 |
Products named: KEYTRUDA, VERZENIO, VENCLEXTA, ENHERTU, KIMMTRAK, Orserdu, LONSURF, KISQALI.
Industry payments across SC — which companies pay providers there.
